Stay updated on Pembrolizumab in Neoplasms Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Neoplasms Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page's revision history shows an addition of 'Revision: v3.3.4' and a removal of 'Revision: v3.3.3'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:16:42.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Adds a Locations section listing study sites in Illinois, Massachusetts, and Nebraska and updates the page revision to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T21:36:46.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Study record dates were updated to include new entries (2025-12-12, 2025-11-19, 2026-03-01) and remove older ones (e.g., 2025-01-03, 2025-08-18, 2024-12-16), with a general update timestamp reflected as 'Last Update Posted'.
    Difference
    0.3%
    Check dated 2025-12-16T20:54:31.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The Publications description now says entries are automatically filled from PubMed and may not be about the study, and the page shows a revision note for v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:31:55.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice that previously appeared on the page. No other visible study details or navigation elements were altered.
    Difference
    0.4%
    Check dated 2025-11-18T07:19:52.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    No significant changes to core study information were detected; the updates appear to be formatting or copy edits rather than changes to eligibility, endpoints, or enrollment numbers. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:03:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Neoplasms Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.